Healthcare -
Biotechnology - NASDAQ - US
$ 14.69
3.89 %
$ 1.49 B
Market Cap
-4.1
P/E
DYN - CHANGE IN WORKING CAPITAL
Change in Working Capital DYN - Dyne Therapeutics, Inc.
26.3 M
LAST VALUE
68.59%
2 YEAR CAGR
112.93%
5 YEAR CAGR
-20.71%
10 YEAR CAGR